Dyfyniad APA

Munisvaradass, R., Kumar, S., Govindasamy, C., Alnumair, K. S., & Mok, P. L. (2017). Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. Int J Mol Sci.

Dyfyniad Arddull Chicago

Munisvaradass, Rusheni, Suresh Kumar, Chandramohan Govindasamy, Khalid S. Alnumair, and Pooi Ling Mok. "Human CD3+ T-Cells With the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells." Int J Mol Sci 2017.

Dyfyniad MLA

Munisvaradass, Rusheni, et al. "Human CD3+ T-Cells With the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells." Int J Mol Sci 2017.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.